Primary Effusion Lymphoma with Extracavitary Presentation and A T-Cell Immunophenotype : A Potential Diagnostic Pitfall

Primary Effusion Lymphoma (PEL) is a unique immunodeficiency-associated malignancy that requires infection with Kaposi sarcoma herpesvirus/human herpesvirus 8 (KSHV/HHV8). Although thought to arise from mature B-lymphocytes, PEL typically has a null Immunophenotype but can very rarely show lineage specific aberrancies, including aberrant T-cell markers. Here we present one such case of PEL where aberrant T-cell markers led to a misdiagnosis of peripheral T-cell lymphoma. We performed a review of the literature to identify similar cases of PEL with strong T-cell antigen expression. Most cases occurred in men who were HIV positive or otherwise immunodeficient. Many were EBV positive. Rare cases demonstrated T-cell receptor gene rearrangements. Postulated theories for the cause of disordered differentiation include immunodeficiency and/or EBV infection. The expression of T-cell antigens on PELs may be a source for error in diagnosis and awareness of this correlation is of practical diagnostic relevance.


Introduction
Primary Effusion Lymphoma (PEL) is a distinct diagnostic entity defined by the World Health Organization (WHO) as a large Bcell neoplasm usually presenting with serous effusions.Requisite for this classification is an association with Human Herpesvirus 8 (HHV8) also known as Kaposi Sarcoma Herpesvirus (KSHV).This association was initially noted in cases of lymphomatous effusions in Human Immunodeficiency Virus (HIV) infected males who had severe immunodeficiency and frequently had a concomitant coinfection with Epstein-Barr Virus (EBV) [1].However, over time, documented cases have shown PEL arising in the setting of solid organ transplants, elderly patients, and HHV8 endemic geographical regions.Not uncommonly, a solid variant termed extracavitary PEL is present with approximately half of patients having a concurrent Kaposi sarcoma [2].Cases of PEL-like lymphomas unre-lated to HHV8 have also been described [3,4].Most cases of PEL's are null Immunophenotype or express some B-cell markers [2].Herein we discuss a case of PEL with T-cell Immunophenotype and review the literature of other reported cases.

Methods and Materials
A literature review was performed to identify reports of PEL with strong immunohistochemical staining for aberrant Tcell marker expression.Cases were selected through a retrospective analysis of Pub med indexed reports using MeSH and non-MeSH queries for the following search terms: primary effusion lymphoma; Primary effusion lymphoma review; and body cavity lymphoma.
Cases with documented HHV8 and T-cell antigen positivity were reviewed.Specific features of each case including patient demographics, clinical presentation, cell morphology, aberrant immunophenotypic markers, and presence of lineage specific gene rearrangement.Reports without sufficient information or documented T-cell antigen positivity were excluded.

Case Report
The patient was a 53-year-old HIV positive male who was diagnosed in 2005, and treated with HAART regimen, but was noncompliant in the past 2 to 3 years.He also had history of treated syphilis, brucellosis, and shingles.In November 2016, he presented to ER with fever, tachycardia and abdominal pain.He reported night sweats, mild dysphagia and approximately 10 lb weight loss in the last two months.Lab work up showed CD4 count 108, HIV viral load 1,050,579 and elevated liver enzymes, Complete blood count showed severe pancytopenia.CT demonstrated a soft tissue mass to the left of the suprarenal aorta, which extended above the diaphragm and lifted the aorta off the spine.Retrocrural, retroperitoneal lymphadenopathy, and hepatosplenomegaly was noted.Chest x-ray revealed a small left pleural effusion.Blood culture was positive for Candida sp. and enterococcus.He underwent para-aortic lymph node biopsy, thoracentesis of the pleural effusion, and bone marrow biopsy.
The lymph node biopsy showed a diffuse pattern of large atypical lymphoid cells and was initially diagnosed as Peripheral T-cell lymphoma, NOS, at an outside hospital due to strong CD3 and CD4 expression by immunohistochemistry (Figure 1; panels A and C).The pleural fluid cytology showed clusters of highly atypical lymphoid cells with high nuclear/cytoplasmic ratios, basophilic cytoplasm, and bizarre appearing nuclei with multiple prominent nucleoli (Figure 1; panel B).The bone marrow biopsy was negative for lymphomatous involvement.Additional immunohistochemical stains performed at UCLA showed strong HHV8 positivity in the atypical cells (Figure 1; panel D).An in-situ hybridization for EBV-EBER was also positive.

Results
Based on the morphologic features, HHV8 positivity and the clinical findings a diagnosis of extracavitary Primary Effusion Lymphoma (PEL) was rendered.Immunohistochemistry demonstrated lymphoma cells positive for CD3 and CD4, HHV8 and EBER with a Ki-67 proliferation index of >90%.The lymphoma cells were negative for CD20, PAX5, CD8, CD30, CD5, CD7, BF1, TCR gamma and ALK-1.Molecular genetic studies demonstrated a clonal immunoglobulin heavy chain rearrangement.The patient was started on chemotherapy with EPOCH: Etoposide, prednisone, Vincristine, Cyclophosphamide, and Doxorubicin.
He was restarted on HAART medication.Unfortunately, he subsequently developed septic shock followed by hypoxic respiratory failure then multiorgan failure.His condition continued to decline, was placed on comfort care in accordance with the family's wishes and passed away peacefully.

Discussion
Prior to the discovery of HHV8, proposed criteria for body cavity lymphoma included a clinical presentation of isolated effusion, characteristic cytomorphology, absence of B-cell or immunoglobulin immunohistochemical markers, clonal immunoglobulin gene rearrangements, and Epstein-Barr virus infection [17,18].Many patients had a concurrent Kaposi's sarcoma diagnosis, which led to the association of KSHV/HHV8 becoming the essential diagnostic factor in PEL.There is strong support for PEL being a B-cell lymphoma.First, the pathogenesis may rely on viral transformation.Hensler et al studied the in vitro virology of KSHV/ HHV8 and identified a glycoprotein interaction with cells through the receptor DC-SIGN (CD209), normally mediating the interactions between antigen presenting cells and helper T-cells and is found primarily on dendritic cells, macrophages, and B-cells [19].Infection is only possible in lymphocytes with B-cell lineage as CD209 receptor is associated with B-cells.In an additional example: Epstein-Barr virus, a frequent co-infectious agent, binds to complement receptor CD21, which also appears on B-cells.Fais et al performed in vitro sequencing studies of immunoglobulin genes and demonstrated clonal rearrangement and statistical evidence for antigen selection.The variable regions in both heavy chains and light chains showed point mutations that differ from the germline, which is associated with and suggests a mature antigen experienced B-cell counterpart [20].In fact, it is notable that many markers of activation and plasma cell differentiation including CD30, CD38, CD138, and EMA are often present.Gene expression profiles examined by Klein et al suggest plasmablastic differentiation similar to other AIDS associated non-Hodgkin lymphomas [21].Despite these observations, rare cases show aberrant expression of lymphoid markers including those of T-cells.In addition, cases may show abnormal genotypic features including T-cell receptor rearrangements and even bigenotypic rearrangements [22].Our literature review suggests that TCR gene rearrangements are not infrequently seen in cases of aberrant T-cell immuno phenotype.The findings of bigenotypic lineage and EBV are associated with immunodeficiency and may be a factor in abnormal differentiation [22].To our knowledge, the mechanism of immunodeficiency in the genetic evolution of lymphoid neoplasms is poorly understood and practical considerations during the diagnosis of PEL and other immunodeficiency-associated lymphomas include an awareness of possible disordered gene expression.In summary, PEL should be included in the differential diagnosis of large cell lymphoid neoplasms even in cases that have an extracavitary mass, HIV negative history, or aberrant lymphoid markers.Although a rare circumstance, an awareness of these scenarios can prevent a possible missed diagnosis.

Citation:
Stelling A, Tan HT, Zalom M, Pullarkat ST (2018) Primary Effusion Lymphoma with Extracavitary Presentation and A T-Cell Immunophenotype: A Potential Diagnostic Pitfall.Int J Clin Pathol Diagn IJCP-119.DOI: 10.29011/2577-2139.000019Volume 2018; Issue 01 Int J Clin Pathol Diagn, an open access journal ISSN 2577-21439 were HIV positive, the remaining patients had other causes for immunodeficiency including four patients with advanced age and one patient with a history of a renal Volume 2018; Issue 01 Int J Clin Pathol Diagn, an open access journal ISSN 2577-21439

Table 1 :
Demographics, clinical characteristics, and pathologic features for similar reported cases.